HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Boldrin Selected Research

BIM 51077

7/2009Treatment with the human once-weekly glucagon-like peptide-1 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone: a double-blind placebo-controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark Boldrin Research Topics

Disease

7Type 2 Diabetes Mellitus (MODY)
05/2017 - 07/2009
5Weight Loss (Weight Reduction)
03/2013 - 06/2005
5Body Weight (Weight, Body)
03/2013 - 10/2006
3Injection Site Reaction
03/2013 - 03/2012
2Overweight
03/2013 - 10/2006
1Headache (Headaches)
05/2017
1Hypoglycemia (Reactive Hypoglycemia)
05/2017
1Hypersensitivity (Allergy)
03/2013
1Nausea
03/2013
1Vomiting
03/2013

Drug/Important Bio-Agent (IBA)

4Glucose (Dextrose)FDA LinkGeneric
01/2016 - 06/2005
4taspoglutideIBA
03/2013 - 07/2009
3Metformin (Glucophage)FDA LinkGeneric
03/2013 - 07/2009
2GlucokinaseIBA
05/2017 - 01/2016
2piragliatinIBA
05/2017 - 01/2016
2Cytochrome P-450 CYP3AIBA
05/2016 - 01/2016
2Glucagon-Like Peptide 1 (GLP 1)IBA
12/2012 - 07/2009
1Moxifloxacin (Avelox)FDA Link
05/2017
1Ethanol (Ethyl Alcohol)IBA
05/2016
1Ketoconazole (Nizoral)FDA LinkGeneric
05/2016
1Rifampin (Rifampicin)FDA LinkGeneric
05/2016
1Simvastatin (Zocor)FDA LinkGeneric
01/2016
12,4-thiazolidinedione (thiazolidinedione)IBA
03/2013
1Exenatide (Byetta)FDA Link
03/2013
1Glucagon-Like Peptide-1 ReceptorIBA
03/2013
1Sitagliptin Phosphate (Januvia)FDA Link
12/2012
1Hypoglycemic Agents (Hypoglycemics)IBA
03/2012
1Pharmaceutical PreparationsIBA
03/2012
1BIM 51077IBA
07/2009
1Orlistat (Xenical)FDA Link
10/2006
1LipidsIBA
06/2005
1Insulin (Novolin)FDA Link
06/2005

Therapy/Procedure

4Glycemic Control
03/2013 - 07/2009
2Therapeutics
10/2006 - 06/2005